Next Article in Journal
Short Toxin-like Proteins Abound in Cnidaria Genomes
Next Article in Special Issue
Verotoxin A Subunit Protects Lymphocytes and T Cell Lines against X4 HIV Infection in Vitro
Previous Article in Journal
Lengthening of Insect Development on Bt Zone Results in Adult Emergence Asynchrony: Does It Influence the Effectiveness of the High Dose/Refuge Zone Strategy?
Previous Article in Special Issue
Shiga Toxins and the Pathophysiology of Hemolytic Uremic Syndrome in Humans and Animals
Review

PI3K/Akt/mTOR, a Pathway Less Recognized for Staphylococcal Superantigen-Induced Toxicity

Department of Immunology, Integrated Toxicology Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, MD 21702, USA
Toxins 2012, 4(11), 1343-1366; https://doi.org/10.3390/toxins4111343
Received: 27 September 2012 / Revised: 12 November 2012 / Accepted: 13 November 2012 / Published: 15 November 2012
(This article belongs to the Special Issue Novel Properties of Well-Characterized Toxins)
Immunostimulating staphylococcal enterotoxin B (SEB) and related superantigenic toxins cause diseases in humans and laboratory animals by activating cells of the immune system. These toxins bind directly to the major histocompatibility complex (MHC) class II molecules on antigen-presenting cells and specific Vβ regions of T-cell receptors (TCR), resulting in hyperactivation of both T lymphocytes and monocytes/macrophages. Activated host cells produce excessive amounts of proinflammatory cytokines and chemokines, especially tumor necrosis factor α, interleukin 1 (IL-1), IL-2, interferon γ (IFNγ), and macrophage chemoattractant protein 1 causing clinical symptoms of fever, hypotension, and shock. The well-explored signal transduction pathways for SEB-induced toxicity downstream from TCR/MHC ligation and interaction of cell surface co-stimulatory molecules include the mitogen-activated protein kinase cascades and cytokine receptor signaling, culminating in NFκB activation. Independently, IL-2, IFNγ, and chemokines from activated T cells signal via the phosphoinositide 3-kinase (PI3K), the serine/threonine kinases, Akt and mammalian target of rapamycin (mTOR) pathways. This article reviews the signaling molecules induced by superantigens in the activation of PI3K/Akt/mTOR pathways leading to staphylococcal superantigen-induced toxicity and updates potential therapeutics against superantigens. View Full-Text
Keywords: staphylococcal superantigens; inflammatory cytokines; signaling pathways; PI3K; Akt; mTOR; therapeutics staphylococcal superantigens; inflammatory cytokines; signaling pathways; PI3K; Akt; mTOR; therapeutics
Show Figures

Figure 1

MDPI and ACS Style

Krakauer, T. PI3K/Akt/mTOR, a Pathway Less Recognized for Staphylococcal Superantigen-Induced Toxicity. Toxins 2012, 4, 1343-1366. https://doi.org/10.3390/toxins4111343

AMA Style

Krakauer T. PI3K/Akt/mTOR, a Pathway Less Recognized for Staphylococcal Superantigen-Induced Toxicity. Toxins. 2012; 4(11):1343-1366. https://doi.org/10.3390/toxins4111343

Chicago/Turabian Style

Krakauer, Teresa. 2012. "PI3K/Akt/mTOR, a Pathway Less Recognized for Staphylococcal Superantigen-Induced Toxicity" Toxins 4, no. 11: 1343-1366. https://doi.org/10.3390/toxins4111343

Find Other Styles

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Back to TopTop